Shanghai ZJ Bio-Tech Co (SHSE:688317) Scaled Net Operating Assets: 0.21 (As of Mar. 2026)


SHSE:688317 Shanghai ZJ Bio-Tech Co Ltd SHSE:688317
69 GF Score
Price ¥15.09
GF Value ¥9.93
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Shanghai ZJ Bio-Tech Co Scaled Net Operating Assets?

Shanghai ZJ Bio-Tech Co SHSE:688317 -3.76% 69 Scaled Net Operating Assets is 0.21 as of Mar. 2026. GuruFocus rates SHSE:688317 with a GF Score™ of 69/100 and a GF Value™ of ¥9.93 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai ZJ Bio-Tech Co's operating assets for the quarter that ended in Mar. 2026 was ¥880.5 Mil. Shanghai ZJ Bio-Tech Co's operating liabilities for the quarter that ended in Mar. 2026 was ¥107.5 Mil. Shanghai ZJ Bio-Tech Co's Total Assets for the quarter that ended in Dec. 2025 was ¥3,763.8 Mil. Therefore, Shanghai ZJ Bio-Tech Co's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.21.

Shanghai ZJ Bio-Tech Co Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai ZJ Bio-Tech Co Scaled Net Operating Assets Chart

Shanghai ZJ Bio-Tech Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.25 0.22 0.21 0.20

Shanghai ZJ Bio-Tech Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.22 0.21 0.20 0.21

SHSE:688317 vs ABT, SYK, MDT: Scaled Net Operating Assets Comparison

For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai ZJ Bio-Tech Co Scaled Net Operating Assets vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets falls into.


SHSE:688317
69GF Score
Shanghai ZJ Bio-Tech Co Ltd SHSE:688317
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai ZJ Bio-Tech Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2025 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2025 )
=(Operating Assets (A: Dec. 2025 )-Operating Liabilities (A: Dec. 2025 ))/Total Assets (A: Dec. 2024 )
=(863.176-115.983)/3789.95
=0.20

where

Operating Assets(A: Dec. 2025 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3763.8 - 2900.624
=863.176

Operating Liabilities(A: Dec. 2025 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=414.951 - 287.227 - 11.741
=115.983

Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(880.528-107.512)/3763.8
=0.21

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=3706.727 - 2826.199
=880.528

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=404.13 - 286.985 - 9.633
=107.512

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.21 mean?
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a Scaled Net Operating Assets of 0.21 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Shanghai ZJ Bio-Tech Co and its competitors.
Is Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets too high?
Shanghai ZJ Bio-Tech Co's current Scaled Net Operating Assets is 0.21. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets compare to ABT and SYK?
Shanghai ZJ Bio-Tech Co's Scaled Net Operating Assets of 0.21 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. Shanghai ZJ Bio-Tech Co's current Scaled Net Operating Assets is 0.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.93, compared to a current price of ¥15.09 — trading 52% above its estimated fair value. The current Scaled Net Operating Assets is 0.21. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current Scaled Net Operating Assets is 0.21 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued. The current stock price of ¥15.09 is trading 52% above its estimated GF Value™ of ¥9.93. GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.

Key valuation signals for SHSE:688317:

  • Scaled Net Operating Assets: 0.21
  • GF Value™: ¥9.93 vs. price of ¥15.09 (52% above fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shanghai ZJ Bio-Tech Co Business Description

Address No. 588 Xinjun Ring Road, Building 26, Pujiang Hi-Tech Park, Caohejing Development Zone, Shanghai, CHN
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
69GF Score

Get the complete analysis for SHSE:688317

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥15.09
Price
¥9.93
GF Value